Simplex Trading’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
– Sell
-147
Closed -$242K – 8699
2020
Q2
$242K Hold
147
– – ﹤0.01% 3786
2020
Q1
$124K Buy
147
+58
+65% +$811 ﹤0.01% 4139
2019
Q4
$201K Buy
89
+13
+17% +$185 ﹤0.01% 3751
2019
Q3
$109K Buy
+76
New +$1.12K ﹤0.01% 4239
2019
Q1
– Sell
-1
Closed -$1K – 8032
2018
Q4
$1K Sell
1
-17
-94% -$299 ﹤0.01% 6813
2018
Q3
$38K Buy
+18
New +$547 ﹤0.01% 5435
2018
Q2
– Sell
-8
Closed -$22K – 7997
2018
Q1
$22K Sell
8
-4
-33% -$283 ﹤0.01% 3275
2017
Q4
$9K Sell
12
-130
-92% -$10.8K ﹤0.01% 4026
2017
Q3
$202K Buy
142
+138
+3,450% +$10.6K 0.01% 1183
2017
Q2
$2K Sell
4
-14
-78% -$1.73K ﹤0.01% 5382
2017
Q1
$13K Buy
18
+16
+800% +$2.29K ﹤0.01% 3740
2016
Q4
$9K Sell
2
-9
-82% -$1.01K ﹤0.01% 3870
2016
Q3
$70K Hold
11
– – ﹤0.01% 1826
2016
Q2
$87K Sell
11
-16
-59% -$1.98K 0.01% 1585
2016
Q1
$183K Buy
27
+15
+125% +$3.04K 0.01% 924
2015
Q4
$37K Buy
12
+1
+9% +$326 ﹤0.01% 2163
2015
Q3
$62K Sell
11
-25
-69% -$11K ﹤0.01% 1820
2015
Q2
$34K Sell
36
-11
-23% -$4.67K ﹤0.01% 1987
2015
Q1
$71K Buy
47
+8
+21% +$3.1K 0.01% 1314
2014
Q4
$78K Buy
+39
New +$11.6K 0.01% 1078

Other funds holding LUMO

Simplex Trading's LUMO Position: Q4 2019 in Review

Simplex Trading sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2019, closing a stake of 3,002 shares — an estimated $42.8K sold.

Simplex Trading first reported a position in LUMO in Q4 2014 and held it in 10 quarters. The position peaked at $1.54M in Q1 2017. 64 funds tracked by Wall St. Rank hold LUMO as of Q4 2019.

  • Simplex Trading reported no remaining Lumos Pharma, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Simplex Trading sold 3,002 Lumos Pharma, Inc. Common Stock shares in Q4 2019, an estimated $42.8K.
  • Simplex Trading first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2014 and held it in 10 quarters.
  • Simplex Trading's Lumos Pharma, Inc. Common Stock position peaked at $1.54M in Q1 2017.
  • 64 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2019.

Based on Simplex Trading's 13F filing for Q4 2019, filed 5 Feb 2020.